Leptin has shown a neuroprotective effect while adiponectin has been associated with poor functional outcomes after AIS.13 It is noteworthy that despite these theoretical possibilities, data on the effect of NAFLD on AIS outcomes is scarce and contradictory. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.